BriaCell Therapeutics Warrant expiring 2031 (BCTXL) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 59 162 sessions, January 14, 2026 to September 17, 2026
- Largest daily move
- -26.6% close of May 15, 2026
Company Description
BriaCell Therapeutics Warrant expiring 2031 (NASDAQ: BCTXL) is classified in the pharmaceutical preparations industry.
BCTXL has gained 21.4% over the past month. The last closing price was $1.02.
For FY2025, BriaCell Therapeutics Warrant expiring 2031 reported net income of -$26.3M and diluted earnings per share of -$62.19.
This page collects what Stock Titan holds for BCTXL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BriaCell Therapeutics Warrant expiring 2031 (BCTXL) closed at $1.02 on September 17, 2026. Over the past month, the price has gained 21.4%.
BCTXL Metrics & Rankings
Price returns through September 17, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
BriaCell Therapeutics Warrant expiring 2031 has filed 6 recent SEC filings, including 3 Form 8-K, 1 Form 424B5, 1 Form 25-NSE, 1 Form DEF 14A. The most recent filing was submitted on June 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BCTXL SEC filings →
Financial Highlights
operating income reached -$27.2M, and net income was -$26.3M. Diluted earnings per share stood at -$62.19. The company generated -$28.2M in operating cash flow. With a current ratio of 5.01, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in BriaCell Therapeutics Warrant expiring 2031 (BCTXL) currently stands at 2.5 thousand shares, down 76.8% from the previous reporting period. Since January 2026, short interest has decreased by 67.5%.
Days to Cover History
Days to cover for BriaCell Therapeutics Warrant expiring 2031 (BCTXL) currently stands at 1.0 days, down 55% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.9 days.
BCTXL Company Profile & Sector Positioning
BriaCell Therapeutics Warrant expiring 2031 (BCTXL) and is listed on the NASDAQ.